| COVID-19 and cardiovascular disease KJ Clerkin, JA Fried, J Raikhelkar, G Sayer, JM Griffin, A Masoumi, ... Circulation 141 (20), 1648-1655, 2020 | 2231 | 2020 |
| The variety of cardiovascular presentations of COVID-19 JA Fried, K Ramasubbu, R Bhatt, VK Topkara, KJ Clerkin, E Horn, ... Circulation 141 (23), 1930-1936, 2020 | 635 | 2020 |
| Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research B Bikdeli, MV Madhavan, A Gupta, D Jimenez, JR Burton, ... Thrombosis and haemostasis 120 (07), 1004-1024, 2020 | 287 | 2020 |
| Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge F Violi, D Pastori, R Cangemi, P Pignatelli, L Loffredo Thrombosis and haemostasis 120 (06), 949-956, 2020 | 279 | 2020 |
| Characteristics and outcomes of recipients of heart transplant with coronavirus disease 2019 F Latif, MA Farr, KJ Clerkin, MV Habal, K Takeda, Y Naka, S Restaino, ... JAMA cardiology 5 (10), 1165-1169, 2020 | 219 | 2020 |
| Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation KJ Clerkin, MA Farr, SW Restaino, E Zorn, F Latif, ER Vasilescu, ... The Journal of Heart and Lung Transplantation 36 (5), 540-545, 2017 | 119 | 2017 |
| Indications for and findings on transthoracic echocardiography in COVID-19 SS Jain, Q Liu, J Raikhelkar, J Fried, P Elias, TJ Poterucha, EM DeFilippis, ... Journal of the American Society of Echocardiography 33 (10), 1278-1284, 2020 | 102 | 2020 |
| Regional differences in recipient waitlist time and pre-and post-transplant mortality after the 2006 United Network for Organ Sharing policy changes in the donor heart … PC Schulze, S Kitada, K Clerkin, Z Jin, DM Mancini JACC: Heart Failure 2 (2), 166-177, 2014 | 83 | 2014 |
| The impact of obesity on patients bridged to transplantation with continuous-flow left ventricular assist devices KJ Clerkin, Y Naka, DM Mancini, PC Colombo, VK Topkara JACC: Heart Failure 4 (10), 761-768, 2016 | 72 | 2016 |
| Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors AK Gupta, H Jneid, D Addison, H Ardehali, AK Boehme, S Borgaonkar, ... Journal of the American Heart Association 9 (12), e017013, 2020 | 68 | 2020 |
| Clinical and hemodynamic effects of intra-aortic balloon pump therapy in chronic heart failure patients with cardiogenic shock JA Fried, A Nair, K Takeda, K Clerkin, VK Topkara, A Masoumi, ... The Journal of Heart and Lung Transplantation 37 (11), 1313-1321, 2018 | 65 | 2018 |
| The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection KJ Clerkin, SW Restaino, E Zorn, ER Vasilescu, CC Marboe, DM Mancini The Journal of Heart and Lung Transplantation 35 (9), 1059-1066, 2016 | 64 | 2016 |
| The prognostic value of electrocardiogram at presentation to emergency department in patients with COVID-19 P Elias, TJ Poterucha, SS Jain, G Sayer, J Raikhelkar, J Fried, K Clerkin, ... Mayo Clinic Proceedings 95 (10), 2099-2109, 2020 | 59 | 2020 |
| Implantable cardioverter-defibrillators in patients with a continuous-flow left ventricular assist device: an analysis of the INTERMACS Registry KJ Clerkin, VK Topkara, RT Demmer, JM Dizon, M Yuzefpolskaya, ... JACC: Heart Failure 5 (12), 916-926, 2017 | 57 | 2017 |
| Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation N Uriel, UP Jorde, SW Pak, J Jiang, K Clerkin, H Takayama, Y Naka, ... The Journal of Heart and Lung Transplantation 32 (2), 188-195, 2013 | 57 | 2013 |
| Constructing bioactive peptides with pH-dependent activities Z Tu, M Volk, K Shah, K Clerkin, JF Liang Peptides 30 (8), 1523-1528, 2009 | 48 | 2009 |
| Admission cardiac diagnostic testing with electrocardiography and troponin measurement prognosticates increased 30‐day mortality in COVID‐19 TJ Poterucha, P Elias, SS Jain, G Sayer, B Redfors, D Burkhoff, ... Journal of the American Heart Association 10 (1), e018476, 2021 | 43 | 2021 |
| ECMO as a bridge to left ventricular assist device or heart transplantation EM DeFilippis, K Clerkin, LK Truby, M Francke, J Fried, A Masoumi, ... Heart Failure 9 (4), 281-289, 2021 | 40 | 2021 |
| Impact of socioeconomic status on patients supported with a left ventricular assist device: an analysis of the UNOS database (United Network for Organ Sharing) KJ Clerkin, AR Garan, B Wayda, RC Givens, M Yuzefpolskaya, ... Circulation: Heart Failure 9 (10), e003215, 2016 | 39 | 2016 |
| Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation SB See, KJ Clerkin, PJ Kennel, F Zhang, MP Weber, KJ Rogers, ... The Journal of Heart and Lung Transplantation 36 (8), 862-870, 2017 | 38 | 2017 |
